Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2016
Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 EnzymesHeather Eng, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 4, 2012
Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymesPhillip Yates, Heather Eng, Li Di, et al.
Anticancer Research|August 10, 2002
Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical responseRoberta B Ness, Stephin R Wisniewski, Heather Eng, et al.
Annals of Human Biology|June 13, 2015
The prevalence of rapid weight gain in infancy differs by the growth reference and age interval used for evaluationCara L Eckhardt, Heather Eng, John L Dills, et al.
Human Vaccines & Immunotherapeutics|March 10, 2022
Estimating the burden of adult hospitalized RSV infection using local and state data - methodologyG K Balasubramani, Mary Patricia Nowalk, Heather Eng, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 12, 2021
Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in NigeriaOgochukwu Amaeze, Heather Eng, Lauren Horlbogen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 3, 2021
Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate ConstantsHeather Eng, Elaine Tseng, Matthew A Cerny, et al.
The AAPS Journal|January 5, 2020
Estimation of the Effect of OAT2-Mediated Active Uptake on Meloxicam Exposure in the Human LiverRui Li, Sumathy Mathialagan, Jonathan J Novak, et al.
Bioanalysis|March 9, 2018
A sensitive method for the quantitation of the peptide-based glucagon-like peptide-1 receptor agonist liraglutide in plasma using microfluidics chromatography tandem MSAmanda J King-Ahmad, Amit S Kalgutkar, Mark Niosi, et al.
Bioanalysis|August 1, 2024
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptorEugene P Kadar, Heather Eng, Amit S Kalgutkar, et al.
Pageof 8